Fig. 2: Spider plot showing the best response as per RECIST 1.1 criteria and duration of response as per histological subtype.

Cohort 1 with niraparib monotherapy (n = 23), and Cohort 2 with niraparib and dostarlimab (n = 22).
Cohort 1 with niraparib monotherapy (n = 23), and Cohort 2 with niraparib and dostarlimab (n = 22).